SCHEMBL8286189

SCHEMBL8286189

Cc1cc2c(c(CN(C)C)n1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.39
GAA P10253 7/20 0.38
HPGD P15428 2/20 0.38
MAPK1 P28482 2/20 0.38
ALDH1A1 P00352 3/20 0.36
LMNA P02545 2/20 0.36
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
TSHR P16473 1/20 0.35
MAT2A P31153 2/20 0.35
GSK3B P49841 3/20 0.34
PDE6D O43924 1/20 0.34
PDE5A O76074 1/20 0.34
PDE6A P16499 1/20 0.34
PDE6G P18545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286460 0.88 PDE11A (0.43) PDE11AGAAHPGDMAPK1ALDH1A1
SCHEMBL8287190 0.87 PDE11A (0.40) PDE11AGAAHPGDMAPK1ALDH1A1
SCHEMBL8286190 0.86 MAPT (0.40) PDE11AGAAHPGDMAPK1ALDH1A1
SCHEMBL8286421 0.86 PDE11A (0.39) PDE11AGAAHPGDMAPK1ALDH1A1
SCHEMBL8287610 0.85 PDE11A (0.39) PDE11AGAAHPGDMAPK1ALDH1A1
SCHEMBL5872043 0.84 GAA (0.41) PDE11AGAAHPGDMAPK1ALDH1A1
SCHEMBL8287209 0.83 PLA2G4A (0.38) PDE11AGAAHPGDMAPK1ALDH1A1
SCHEMBL8362920 0.83 PDE11A (0.38) PDE11AGAAHPGDMAPK1ALDH1A1
SCHEMBL8287934 0.83 MAT2A (0.43) PDE11AGAAHPGDMAPK1ALDH1A1
SCHEMBL5872108 0.83 GAA (0.44) PDE11AGAAHPGDMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed